CPC C07K 16/1081 (2013.01) [A61P 31/14 (2018.01); A61K 2039/505 (2013.01); C07K 2317/33 (2013.01); C07K 2317/52 (2013.01); C07K 2317/56 (2013.01); C07K 2317/567 (2013.01); C07K 2317/71 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01)] | 2 Claims |
1. A method for treating Zika virus infection, comprising administering an antibody that binds to Zika virus, wherein the antibody comprises:
a VH comprising the amino acid sequence of SEQ ID NO: 6,
a human IgG1 CH comprising the amino acid sequence of SEQ ID NO: 59,
a VL comprising the amino acid sequence of SEQ ID NO: 7, and
a human CL.
|